About MCTec
MCTec is a world leader in coating technology for medical applications. The company was formed in
1999 and has its headquarters in Venlo, the Netherlands.
MCTec has pioneered and grown the technology of reel-to-reel wire and polymer tube coating. We have
perfected reliable,cost-efficient coating processes for the medical industry. It is these processes that
ensure the very highest levels of quality coated wire and tubing.
We work closely with the medical establishment to ensure that our products meet and exceed
established needs. Furthermore, our extensive R&D department has direct links with a number of
key research institutes. This helps us to identify future needs, and to develop timely solutions
Our Mission
In open cooperation with our customers, suppliers and each other, we have set ourselves the goal of
developing, manufacturing and marketing superior coatings, coating technologies and coated products.
These products will help to improve diagnostics and treatment in the medical sector.
All MCTec employees will contribute through expertise, experience and enthusiasm, resulting in
excellent products and in the growth in volume and profitability of the company.
History
It started in 1990, at the Innovation Department of Pope Cable and Wire, a Philips Electronics company. Hans Hanssen and Emiel Lenders started to experiment with using the coating process for enamelled copper wires for other purposes. They soon found that coating stainless steel with PTFE would be suitable for medical applications. So they developed a new process for this purpose. In 1994, the Innovation department began the development of hydrophilic coatings. The result is known today as the patented SlipSkin™ hydrophilic coating.
Over time, the Innovation department developed an increasing number of contacts in the medical world, and established itself as a separate business entity. Belden Wire & Cable acquired Pope
Cable & Wire and joined forces with the University of Maastricht and Biomat. In 1999, they formed MCTec to commercialise medical applications for its reel-to-reel coating process. In early 2001,
STS Biopolymers (Henrietta, New York) acquired MCTec, and in December 2003, all assets of STS Biopolymer (including MCTec) were acquired by Angiotech Pharmaceuticals Inc.
As a separate business entity, MCTec develops more and more new coating applications for medical purposes. Some examples include Heparin-releasing coating and a PTFE-coated hypotube for PTCA applications. In 2004 MCTec launched its first prototype of hydrophilically-coated polymer tube. This was developed throughout the course of 2005 and 2006.
On January 1 2006, the MCTec shares were acquired by Merit Medical Systems. Merit Medical Systems supplies the medical world with a range of OEM components, such as torque devices,
injected moulded parts and syringes.
Our Shareholder
Since January 1, 2006, Merit Medical Systems Inc. is the shareholder of MCTec b.v.
Merit Medical Systems, Inc. (NASDAQ, MMSI) was founded in 1987 by Fred P. Lampropoulos, and Kent W. Stanger, Chief Financial Officer.
Merit develops, manufactures and markets single-use medical devices primarily for diagnosing and treating cardiovascular and vascular disease. Merit has been successful in introducing and marketing innovative, high-quality products through its expertise in new product design and its capabilities in injection and insert molding of plastics; the application of its proprietary electronic and sensor-based technologies; and wire, extrusion and catheter technologies.
Merit is utilising its competitive advantages and technologies to develop and offer products that address a wide range of needs related to cardiology and radiology procedures performed in hospitals. Sales are made primarily to U.S. hospitals through a direct sales force. Merit markets its products in over 60 countries worldwide, utilising a direct sales force in Europe, and distributors for the remainder of the world.
Website Merit Medical Systems, Inc.
